mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-08 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
CH5424802 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0005 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0005 |